Stock Suspensions/Halts 04/09/2018 04/06/2018 PCRX

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
170
Stock Suspensions/Halts 04/09/2018

04/06/2018 PCRX Pacira Pharmaceuticals, Inc. Common Stock No Tier Halted
04/06/2018 OGEN Oragenics, Inc. Common Stock No Tier Halted
04/06/2018 LFIN LongFin Corp. Common Stock No Tier Halted
04/06/2018 INCY Incyte Corp. Common Stock No Tier Halted
04/06/2018 AMHPF Verde Agritech PLC Ordinary Shares OTCQB Halted
04/05/2018 SYTHF Syncordia Technologies & Healthcare Solutions Corp Ordinary Shares Grey Market Halted
04/05/2018 LMRMF Lomiko Metals Inc. Ordinary Shares OTCQB Halted
04/05/2018 BHHKF Benchmark Botanics Inc. Ordinary Shares Pink Current Halted
04/04/2018 IVWFF LeadFX INC Ordinary Shares Pink Current Halted
04/04/2018 CNAT Conatus Pharmaceuticals Inc. Common Stock No Tier Halted
04/04/2018 AYI Acuity Brands, Inc. (Holding Company) Common Stock No Tier Halted
04/03/2018 VGGOF Vogogo, Inc. Ordinary Shares OTCQB Halted
04/03/2018 RIGL Rigel Pharmaceuticals, Inc. Common Stock No Tier Halted
04/03/2018 PENYF Pentanova Energy Corp. Ordinary Shares Grey Market Halted
04/03/2018 NWURF Captor Cap Corp. Ordinary Shares Pink Current Halted
04/03/2018 LONCF Loncor Resources Inc. Ordinary Shares Pink Current Halted
04/03/2018 LFDEF UrtheCast Corp Ordinary Shares Pink Current Halted
04/03/2018 CGIP Celadon Group, Inc. Common Stock Pink No Information Halted
04/03/2018 CFGMF California Gold Mining Inc. Ordinary Shares OTCQX International Halted
04/02/2018 UBMRF Urbanimmersive Inc. Ordinary Shares Pink Current Halted
04/02/2018 TCLAF Transcontinental Inc. Ordinary Shares Pink Current Halted
04/02/2018 JRJR JRjr33, Inc. Common Stock Pink No Information Halted
04/02/2018 JMBRF James Bay Resource Ltd. Ordinary Shares Grey Market Halted
04/02/2018 CYXTF Cryptoglobal Corp. Ordinary Shares Grey Market Halted
04/02/2018 BNEFF Bonterra Energy Corp. Ordinary Shares Pink Current Halted
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading